Analytical Solutions for Cell & Gene Therapy

Analytical_Solutions_for
With the approval of mRNA vaccines for COVID-19, there is a surge of mRNA therapeutics from malaria, HIV, cancer vaccines to mRNA/gRNA gene-editing treatments for cardiovascular diseases with endless possibilities. Lipid nanoparticles (LNPs) are often the delivery choice to effectively deliver and target the cells of interest. In order to produce safe and effective drugs, manufacturers of these modalities must characterize mRNA and the LNPs. Analytical tools such as LC-MS can accurately provide the necessary information to help address critical quality attributes.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

USRM Successfully Launches Stem Cell

U.S. Stem Cell, Inc

Dr. Kristin Comella, Chief Science Officer of U.S. Stem Cell, Inc. a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the successful launch of an open, livestream webinar series designed to inform and educate the public on the benefits and applications of stem cell therapy.
Watch Now

Basic Bioinformatics QSAR Study

solusiriset.com

This program is free, please fill in your complete data: Zoom link and other information will be sent to your email, please write your email correctly. If you want to follow information updates related to bioinformatics.
Watch Now

Smarter sample preparation for single-cell sequencing

Multiomic profiling of cell populations at single-cell resolution is revolutionizing scientists’ understanding of complex biological mechanisms.
Watch Now

GEN 40th Anniversary: Getting the Band Back Together

In celebration of GEN’s 40th year in publishing, GEN Live will feature a panel of biotech reporters and scientists who have been covering the bioindustry since the early 1980s. Moreover, each wrote some of their initial biotech articles for GEN just as the industry, and GEN, was taking off.
Watch Now

Spotlight

resources